Molecular profiling demonstrates concurrent upregulation of IL-17A and IL-12/23p40 in cutaneous, lymphatic, and splenic tissues, paralleling findings in psoriasis patients with A20 haploinsufficiency (71). Here, TNFAIP3 is linked to psoriasis.